On the afternoon of May 16th, Huang Weijun, Secretary of the Party Leadership Group and Director of Fujian Medical Products Administration, along with his delegation, conducted a research visit to Sino Universal Pharma. They were accompanied by Fang Liangdong, Deputy Director of the Management Committee of Pingtan Comprehensive Experimental Zone, Bao Youcun, Full-time Deputy Secretary of the Party Committee of the Provincial Medical Products Administration, and Zhang Yong, Director of the Drug Circulation Supervision Department of the Provincial Medical Products Administration.

Director Huang and his delegation first visited the product exhibition hall to gain a detailed understanding of the development process, corporate positioning, and product layout of SUP. The Quality Management Department presented the market situation of the products that have been approved for marketing and the operation of products selected in national procurement projects. The visiting delegation highly praised SUP for actively embracing national policies and participating in national procurement to save healthcare costs and provide Chinese citizens with more high-quality global medicines.

Subsequently, the visiting delegation toured the pharmaceutical storage area, and Director Huang stated, "The quality and safety of pharmaceutical products are the cornerstone of the company's high-quality development. All colleagues should always prioritize quality and safety." After receiving a detailed report on the warehouse operation process, the delegation gave full recognition to SUP' comprehensive quality system and the awareness of building a strong pharmaceutical safety defense among all staff members.

During the visit to the company's office area, Director Huang expressed that SUP's "Global Pharmaceutical One-Stop Distribution Management Service Provider" model, designed around industry policies and market demands, possesses new impetus for platform development. With a focus on China and a global perspective, SUP is well-positioned to stimulate the vitality of the pharmaceutical industry and meet the diverse medication needs of the people. As the pharmaceutical industry rapidly develops, drug regulation will continuously play a guiding role, employing scientific regulatory measures to promote innovative development, unleash industry vitality, and always safeguard the safety of people's medication. This will further enhance the happiness, sense of achievement, and security of the general public.